AG-L-5968, with the CAS number 793035-88-8, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a selective inhibitor of certain protein kinases, which play crucial roles in various cellular processes, including cell growth and division. The compound's structure typically features a core that allows for specific interactions with its target enzymes, contributing to its efficacy in modulating signaling pathways associated with diseases such as cancer. AG-L-5968 is often evaluated in preclinical studies to assess its pharmacological properties, including its potency, selectivity, and safety profile. Additionally, its solubility and stability under physiological conditions are important factors that influence its bioavailability and therapeutic potential. As research continues, AG-L-5968 may provide insights into the development of targeted therapies aimed at improving treatment outcomes for specific conditions.

AG-L-5968

793035-88-8: AG-L-5968, with the CAS number 793035-88-8, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a selective inhibitor of certain protein kinases, which play crucial roles in various cellular processes, including cell growth and division. The compound's structure typically features a core that allows for specific interactions with its target enzymes, contributing to its efficacy in modulating signaling pathways associated with diseases such as cancer. AG-L-5968 is often evaluated in preclinical studies to assess its pharmacological properties, including its potency, selectivity, and safety profile. Additionally, its solubility and stability under physiological conditions are important factors that influence its bioavailability and therapeutic potential. As research continues, AG-L-5968 may provide insights into the development of targeted therapies aimed at improving treatment outcomes for specific conditions.

<p>O6BTG-C8-αGlu is an O6-methylguanine-DNA methyltransferase (MGMT) inhibitor with an IC50 of 0.45 μM. At a concentration of 0.1 μM, it fully inhibits MGMT in HeLaS3 cells and demonstrates no cytotoxicity even at prolonged high doses (up to 20 μM). This compound is suitable for research on MGMT-related cancers.</p>

CAS 793035-88-8

AG-L-5968

O6BTG-C8-αGlu

Ref: TM-T205643